A call for deeper understanding of AFib, a growing and dangerous heart rhythm disorder

April 16, 2018, American Heart Association
A call for deeper understanding of AFib, a growing and dangerous heart rhythm disorder
Credit: American Heart Association

Much of what doctors and researchers know about treating atrial fibrillation is based simply on the yes-no question of whether a patient has the condition or not.

But this all-too-common heart rhythm disorder is much more complicated than that – and a new scientific statement published Monday in the American Heart Association's journal Circulation urges the medical and research community to take a deeper dive into how much AFib a person has, and AFib risk factors and outcomes. The AHA's statements, written by volunteer committees of scientists and doctors, are intended to point out trends or questions in current research that impact the diagnosis and treatment of heart and conditions.

"Our aim is to bring awareness of this concept of measuring the AFib burden and then to outline what we know about it, and identify the knowledge gaps, so more research can be done to fill in those gaps," said Dr. Lin Yee Chen, chair of the statement's writing committee and a tenured associate professor of medicine at the University of Minnesota Medical School.

AFib, a quivering or irregular beat in the heart's upper chambers, which increases the risk of blood clots, affects up to 6.1 million people in the United States. Researchers expect that number to double by 2050. Untreated, AFib doubles the risk of heart-related death and increases a person's chance of having a stroke fivefold.

The new statement encourages a more robust look at a person's status with AFib – measuring the "burden" by determining how long and how frequently a person is in AFib during a set period of time. Then, evaluating that burden and its connections with outcomes such as stroke and cognitive function, as well as a person's lifestyle risks, such as inactivity, obesity and high blood pressure.

Typically, AFib is classified as paroxysmal, persistent or permanent, depending on how long the out-of-rhythm heart episodes last.

More research is needed to determine how all of that plays into the risk for stroke, said Chen, who also is a cardiac electrophysiologist. They conduct tests to study the electrical activity of the heart.

The AHA already plans to fund more atrial fibrillation research. It will accept applications for its Strategically Focused Research Network this summer through January. The work also will receive funding from an AHA partnership with the Patient-Centered Outcomes Research Institute, which hopes to help create tools for AFib patients and their doctors to make decisions on the use of anticoagulants.

The new scientific statement is needed because of a raft of recent advances in blood thinners, called anticoagulants, and other tools to diagnose, treat and manage AFib, said Dr. Karen Furie, a stroke neurologist who also was on the statement's writing committee.

"It's a very frightening condition for people who are aging in a relatively healthy way and suddenly develop this high-risk condition that has the potential to cause significant disability through stroke," said Furie, chair of neurology at Brown University's Alpert Medical School. "It's a major public health concern, given the impact."

The risk of AFib increases with age and is the most common heart arrhythmia in people over the age of 65. One in four people who are 40 years old and older are at risk for developing AFib.

Furie said many people diagnosed with AFib are not being prescribed any type of anticoagulant, despite research that shows the effectiveness of blood thinners in preventing AFib-related stroke. A new wave of blood thinners, she said, don't require regular blood tests or carry the same bleeding risk of previous medicines such as warfarin.

"We now have a very viable alternative, and yet we still see many high rates of patients who are not being treated" with , she said. "The reasons for that are complex, but it's incumbent on the system and third-party payers to try and change that, and to ensure that everyone with atrial fibrillation is on appropriate medical therapy."

Chen said the statement's call for more research is crucial.

"We need to address this question of the amount of AFib, which is increasingly an urgent question," he said. "More and more people have devices that are detecting asymptomatic runs of AFib and we have little or no guidance on how to manage these patients."

For the public, Furie said, the big message is awareness.

"An irregular heart rhythm, if a person feels fine, may seem inconsequential when, in fact, it is increasing the risk of a devastating stroke," she said. "This is a major threat to leading an independent high-quality life. The second message is there are strategies for dramatically reducing that risk. … It's very important that people who are middle to older age be talking to their medical providers and have some type of screening to see if they may be in ."

Explore further: Common genetic variant linked to AFib risk in Latinos

Related Stories

Common genetic variant linked to AFib risk in Latinos

April 9, 2018
"There is a paradox at play when it comes to atrial fibrillation in the Latino population," said Dr. Dawood Darbar.

Study backs up connection between atrial fibrillation and dementia

March 7, 2018
One of the longest and most comprehensive studies to date has found more evidence that people diagnosed with a type of rapid or irregular heartbeat called atrial fibrillation may be at greater risk for cognitive decline and ...

Avoiding alcohol helps the heart beat better

October 19, 2017
(HealthDay)—The longer you refrain from drinking, the lower your risk of a common heart rhythm disorder.

Guidelines suggest blood thinners for more women, seniors with AFib

March 2, 2015
Nearly all women and people over 65 in the U.S. with atrial fibrillation are advised to take blood thinners under new guidelines based on an analysis from the Duke Clinical Research Institute.

Increasing percentage of patients aware of link between atrial fibrillation and stroke

September 6, 2012
(Medical Xpress)—Findings from a recent American Heart Association/American Stroke Association survey noted the increased awareness in patients suffering from atrial fibrillation and the correlation between this condition ...

New blood thinners reduce atrial fibrillation stroke risk without frequent monitoring

April 13, 2016
A new generation of blood thinners can reduce the risk of stroke in patients with atrial fibrillation, without requiring frequent monitoring and dietary restrictions.

Recommended for you

Researchers discover new genes associated with heart function

July 17, 2018
A new study from an international research team, led by Dr. Yalda Jamshidi at St George's, University of London, has identified new genes associated with heart function and development.

Southern diet could be deadly for people with heart disease

July 12, 2018
People with a history of heart disease who eat a traditional Southern diet are more likely to die than those who follow a Mediterranean dietary pattern, according to new research.

Late-life high blood pressure may harm the brain, study says

July 11, 2018
Decades ago, hundreds of nuns and priests made an extraordinary decision: They agreed to donate their brains upon death to science, hoping to help solve mysteries about Alzheimer's and other diseases. Now, a study that used ...

Multivitamins do not promote cardiovascular health

July 10, 2018
Taking multivitamin and mineral supplements does not prevent heart attacks, strokes or cardiovascular death, according to a new analysis of 18 studies published in Circulation: Cardiovascular Quality and Outcomes, an American ...

Mobile health devices diagnose hidden heart condition in at-risk populations

July 10, 2018
Wearable mobile health devices improved the rate of diagnosis of a dangerous and often hidden heart condition called atrial fibrillation (AFib), according to a first of its kind, home-based clinical study conducted in part ...

Chronic heart disease poses high financial burden to low-income families

July 3, 2018
The financial burdens of long-term care for a family member with atherosclerotic cardiovascular disease (ASCVD) disproportionately affect low-income American families, even those who have insurance, found researchers at Yale ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.